IP Library Granted Patent US 7,485,607
Granted Patent B2
US 7,485,607 · App. 12/127,050 · Granted Feb 3, 2009

Compositions and methods for inhibiting protein on surfaces

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,485,607
App. No.
12/127,050
Granted
Feb 3, 2009
Kind
B2
Abstract

The use of NIPAM polymers to prevent or reduce the formation of protein deposits on the surfaces of medical devices is described. The invention is particularly directed to reduction of the adsorption of proteins on surfaces of contact lenses and other medical prosthetics.

Claims (8)

1. A method of modifying a surface of a contact lens or intraocular lens which comprises applying a solution to said surface of said contact lens or intraocular lens, said solution comprising an amount of a NIPAM polymer and an ophthalmically acceptable vehicle therefore wherein the amount of NIPAM polymer is sufficient to modify said surface such that adsorption of proteins to said surface is inhibited and wherein the modification of the surface occurs before the contact lens or intraocular lens is exposed to a protein containing fluid of a consumer.

2. The method of claim 1 wherein the solution contains the NIPAM polymer in an amount sufficient to provide the solution with a surface tension of less than 50 mnM −1 at a temperature of 23° C.

3. The method of claim 2 wherein the application of the solution to said surface modifies said surface so that the adsorption of proteins to said surface is inhibited.

4. The method of claim 3 wherein the solution is a sterile, aqueous solution.

5. The method of claim 4 wherein the solution is a multi-purpose solution suitable for treating contact lenses on a daily basis and comprises an effective amount of a surfactant.

6. The method of claim 5 wherein the solution contains an ophthalmically acceptable antimicrobial agent in an amount effective to disinfect a contact lens.

7. The method of claim 4 wherein the solution has a physiologically compatible pH and an osmolality of 200 to 400 mOsm/kg.

8. The method of claim 1 wherein the protein containing fluid is a tear fluid.

Assignments (1)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →